« Alle Studien

ADVANCE Studie

Action in Diabetes and Vascular disease - preterAx and diamicroN modified release Controlled Evaluation (2)

Literaturstellen

N.Engl.J.Med. 2008,358,2560; 2008,359,1521; 2010,363,1410
Hypertension 2009,54,399; 2015,65,115; 2017,70,461; 2019,73,84
J.Am.Soc.Nephrol. 2009,20,883; 1813
Vasc.Health Risk Manag. 2009,5,859
J.Am.Soc.Nephrol. 2009,20,883
J.Am.Coll.Cardiol. 2009,53,298; 2010,56,1908
Eur.Heart J. 2009,30,1128; 1385; 2010,31,1845
Eur.Heart J. 2009,30,1128; 2010,31,2888
Am.J.Cardiovasc.Drugs 2009,9,283
J.Hypertens. 2010,28,1141; 2011,29,1439
J.Am.Coll.Cardiol. 2010,56,1908
Med.J.Aust. 2010,193,320
LoS Med. 2010,7,e1000236; 2013,8,e55807; 2013,8,e55807
J.Cardiovasc.Pharmacol. 2010,55,340
Eur.J.Cardiovasc.Prev.Rehabil. 2011,18,312; 393
Eur.Psychiatry 2011,28,49
J.Am.Heart Assoc. 2012,1,e002832; 2018,7,e008226;